2024年全国胸痛中心质控报告

ChestpaincenterofChinaqualityreport 组织编写单位：国家放射与治疗临床医学研究中心胸痛中心专家委员会苏州工业园区东方华夏心血管健康研究院 摘要 第一部分中国胸痛中心组织管理体系··································································4第二部分中国胸痛中心验收体系········································································6一、中国胸痛中心验收标准·······················································································7二、胸痛中心建设与管理流程····················································································7第三部分中国胸痛中心质控体系········································································8一、中国胸痛中心外部质控工作机制··········································································9二、胸痛中心常态化质控的有效工具··········································································9第四部分中国胸痛中心建设情况·······································································10一、中国胸痛中心验收/建设数量·············································································11二、各省胸痛中心建设情况·····················································································111.各省二级以上医院胸痛中心建设比例（注册数量/二级以上医院数量）····················122.各省胸痛中心注册数量情况············································································123.各省胸痛中心验收数量情况············································································134.各省胸痛中心验收通过率（通过验收数量/注册总数）·········································135.各省每百万常住人口胸痛中心数量···································································14三、各省胸痛中心救治高危胸痛患者情况···································································15四、标准版胸痛中心关键指标分析············································································171.全部STEMI患者发病到首次医疗接触（S2FMC）时间·············································172.行PPCI治疗的STEMI患者入门至导丝通过（D2W）时间········································193.全部STEMI患者来院方式···············································································204.发病12h以内STEMI患者接受再灌注治疗的比例·················································215.STEMI患者出院带药符合指南推荐的比例···························································226.STEMI患者院内死亡率···················································································237.STEMI患者平均住院天数················································································248.STEMI患者平均住院费用················································································25 五、基层版胸痛中心关键指标分析············································································261.全部STEMI患者发病到首次医疗接触（S2FMC）时间·············································262.行PPCI治疗的STEMI患者入门至导丝通过（D2W）时间········································283.行转运PCI治疗的STEMI患者在非PCI医院的入门至出门(DIDO)时间·····················294.行溶栓治疗的STEMI患者入门至开始溶栓（D2N）时间·········································305.全部STEMI患者来院方式···············································································316.发病12h以内STEMI患者接受再灌注治疗的比例·················································327.STEMI患者出院带药符合指南推荐的比例···························································338.STEMI患者院内死亡率···················································································339.STEMI患者平均住院天数················································································3510.STEMI患者平均住院费用···············································································36第五部分胸痛中心随访工作总结·······································································37第六部分胸痛救治单元建设总结·······································································40第七部分全国心电一张网·心电诊断中心建设总结···············································43第八部分智慧胸痛中心建设总结·······································································47第九部分中国胸痛中心2024年重点工作总结······················································47一、全国胸痛中心验收及建设数量持续提升，形成全国胸痛救治网络······························48二、进一步优化胸痛中心质控管理，提升救治质量·······················································48三、建设急性胸痛患者县乡村一体化救治体系·····························································49四、构建心脏危重症救治体系，降低死亡率，提升医疗水平··········································49五、推进智慧胸痛中心建设，完善有序、连接、高效的“智慧”胸痛救治体系··················49六、持续推进心电一张网·心电诊断中心建设，发布团体标准·······································49七、大湾区胸痛中心一体化建设启动，积极推动大湾区胸痛中心网络建设························50八、规范胸痛中心生物标志物检测，助推诊疗质量提升·················································50九、广泛开展公众教育，提升群众健康素养································································50十、提升胸痛中心大数据建设与科研，助力胸痛中心救治··············································50第十部分中国胸痛中心2025年工作规划····························································51附件《胸痛中心质控指标及考核办法》（第三版修订版）发布通知·························54 摘要 中国胸痛中心自2013年建立自主验收体系，目前已经形成一整套完整、严谨、科学的建设标准和评审流程，全国胸痛中心建设在国家放射与治疗临床医学研究中心指导下，由国家胸痛中心专家委员会统一组织推动，组织架构主要由国家胸痛中心专家委员会指导下的协调工作组织机构与专家体系组成。中国胸痛中心截至2024年12月，注册单位5947家，通过验收2994家（标准版1408家、基层版1586家），全国331个地市（州）至少有一家胸痛中心，全国实现县域96%覆盖。 2024年国家胸痛中心专家委员会在国家放射与治疗临床医学研究中心的指导下，持续推动全国胸痛中心科学、规范地建设与发展。①全国胸痛中心验收及建设数量持续提升，形成全国胸痛救治网络；②进一步优化胸痛中心质控管理，提升救治质量；③建设急性胸痛患者县乡村一体化救治体系；④构建心脏危重症救治体系，降低死亡率，提升医疗水平；⑤推进智慧胸痛中心建设，完善有序、连接、高效的“智慧”胸痛救治体系；⑥持续推进心电一张网·心电诊断中心建设，发布团体标准；⑦大湾区胸痛中心一体化建设启动，积极推动大湾区胸痛中心网络建设；⑧规范胸痛中心生物标志物检测，助推诊疗质量提升；⑨广泛开展公众教育，提升群众健康素养；⑩提升胸痛中心大数据建设与科研